| Panel Co-Chairs |
| John G. Bartlett |
Johns Hopkins University, Baltimore, MD |
| H. Clifford Lane |
National Institutes of Health, Bethesda, MD |
| Executive Secretary |
| Alice K. Pau |
National Institutes of Health, Bethesda, MD |
| Scientific Members |
| Judith Aberg |
New York University, New York, NY |
| Adaora Adimora |
University of North Carolina, Chapel Hill, NC |
| John T. Brooks |
Centers for Disease Control and Prevention, Atlanta, GA |
| Deborah L. Cohan |
University of California–San Francisco, San Francisco, CA |
| Eric Daar |
University of California–Los Angeles, Harbor-UCLA Medical Center, Los Angeles, CA |
| Steven G. Deeks |
University of California–San Francisco, San Francisco, CA |
| Carlos del Rio |
Emory University, Atlanta, GA |
| Robert T. Dodge |
University of North Carolina, Chapel Hill, NC |
| Courtney V. Fletcher |
University of Nebraska Medical Center, Omaha, NE |
| Gerald Friedland |
Yale University School of Medicine, New Haven, CT |
| Joel E. Gallant |
Johns Hopkins University, Baltimore, MD |
| Stephen J. Gange |
Johns Hopkins University, Baltimore, MD |
| Christopher M. Gordon |
National Institutes of Health, Bethesda, MD |
| Roy M. Gulick |
Weill Medical College of Cornell University, New York, NY |
| W. Keith Henry |
Hennepin County Medical Center & University of Minnesota, Minneapolis, MN |
| Michael D. Hughes |
Harvard School of Public Health, Boston, MA |
| Bill G. Kapogiannis |
National Institutes of Health, Bethesda, MD |
| Daniel R. Kuritzkes |
Brigham and Women’s Hospital & Harvard Medical School, Boston, MA |
| Richard W. Price |
University of California–San Francisco, San Francisco, CA |
| Michael Saag |
University of Alabama at Birmingham, Birmingham, AL |
| Paul Sax |
Brigham and Women’s Hospital & Harvard Medical School, Boston, MA |
| Mark Sulkowski |
Johns Hopkins University, Baltimore, MD |
| Zelalem Temesgen |
Mayo Clinic, Rochester, MN |
| Phyllis Tien |
University of California–San Francisco, San Francisco, CA |
| Rochelle Walensky |
Massachusetts General Hospital & Harvard Medical School, Boston, MA |
| David A. Wohl |
University of North Carolina, Chapel Hill, NC |
| Community Members |
| Lei Chou |
Treatment Action Group, New York, NY |
| Paul Dalton |
San Francisco, CA |
| Heidi Nass |
Madison, WI |
| Jeff Taylor |
AIDS Treatment Activists Coalition, Palm Springs, CA |
| Nelson Vergel |
Program for Wellness Restoration, Houston, TX |
| Members Representing Department of Health and Human Services Agencies |
| Victoria Cargill |
National Institutes of Health, Rockville, MD |
| Laura Cheever |
Health Resources and Services Administration, Rockville, MD |
| Jonathan Kaplan |
Centers for Disease Control and Prevention, Atlanta, GA |
| Kendall Marcus |
Food and Drug Administration, Silver Spring, MD |
| Henry Masur |
National Institutes of Health, Bethesda, MD |
| Lynne Mofenson |
National Institutes of Health, Bethesda, MD |
| Kimberly Struble |
Food and Drug Administration, Silver Spring, MD |
| Non-Voting Observer |
| Monica Calderon |
National Institutes of Health, SAIC-Frederick, Inc., NCI-Frederick, Frederick, MD |
| Acknowledgement |
| The Panel would like to acknowledge the assistance of Sarita D. Boyd, Pharm.D. (Food and Drug Administration) for her assistance in updating the drug interaction tables, and Thomas Uldrick, M.D. (National Cancer Institute) for his assistance with the Malignancies discussion located in the Initiating Antiretroviral Therapy in Treatment-Naive Patients section. |